Browse Category

Earnings Reports News 27 January 2026

Meta stock jumps on $6 billion Corning AI cable deal as earnings loom

Meta stock jumps on $6 billion Corning AI cable deal as earnings loom

Meta shares rose about 2% to $672.36 early Tuesday after the company agreed to pay Corning up to $6 billion for fiber-optic cables supporting AI data centers. Corning will expand production in Hickory, North Carolina, with payments running through 2030. The deal comes ahead of Meta’s earnings report Wednesday, as investors focus on rising infrastructure costs. The EU set a mid-May 2026 compliance deadline for WhatsApp channels under new digital rules.
Apple stock price today: AAPL climbs at the open as $315 target meets earnings week

Apple stock price today: AAPL climbs at the open as $315 target meets earnings week

Apple shares rose 1.7% to $259.73 early Tuesday, extending Monday’s 3% gain ahead of its January 29 earnings report. JPMorgan raised its Apple price target to $315, while Jefferies cut its target to $276.47. The stock traded between $258.66 and $260.13 Tuesday morning. Investors are watching for the Fed’s rate decision and major tech earnings later this week.
Microsoft stock rises as MSFT heads into earnings after Maia 200 AI chip reveal

Microsoft stock rises as MSFT heads into earnings after Maia 200 AI chip reveal

Microsoft shares rose 0.9% to $470.28 in early U.S. trading Tuesday ahead of its fiscal Q2 earnings report due Jan. 28. Investors are focused on Azure’s growth and Microsoft’s new Maia 200 AI chip, which launches this week in Iowa. The Federal Reserve also begins a two-day policy meeting, adding to market uncertainty.
Broadcom stock price rises as Wall Street sets up for Fed call and big-tech earnings (AVGO)

Broadcom stock price rises as Wall Street sets up for Fed call and big-tech earnings (AVGO)

Broadcom shares rose 1.5% to $324.85 in early Tuesday trading, leading chip stocks higher after Micron’s $24 billion Singapore plant announcement. Investors shifted into top tech names ahead of the Federal Reserve’s rate decision and a wave of mega-cap earnings. Focus remains on whether AI spending will lift profits amid margin concerns.
ASML stock rises ahead of Q4 earnings — here’s what investors are watching

ASML stock rises ahead of Q4 earnings — here’s what investors are watching

ASML shares climbed 1.1% to near 1,190 euros in Amsterdam Tuesday, ahead of its Q4 and full-year earnings due Wednesday. Evercore ISI reaffirmed its buy rating with a 1,300-euro target; Barclays kept a hold at 1,200 euros. Investors are watching for any upgrade to ASML’s 2026 sales outlook amid strong AI chip demand. CEO Christophe Fouquet will address the media at 1100 CET after results.
Wall Street futures rise ahead of Fed decision as Medicare rate plan hits insurers, earnings roll in

Wall Street futures rise ahead of Fed decision as Medicare rate plan hits insurers, earnings roll in

S&P 500 and Nasdaq futures rose early Tuesday, while Dow futures slipped, weighed by UnitedHealth after Washington proposed keeping Medicare Advantage payments nearly flat for 2027. Insurers fell in premarket trading. Investors awaited earnings reports and the Federal Reserve’s policy decision due Wednesday. Salesforce shares gained on news of a $5.6 billion U.S. Army contract.
Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

Dow futures fell 40 points premarket Tuesday as UnitedHealth dropped 8.6% after a proposed Medicare Advantage rate increase came in far below expectations. S&P 500 and Nasdaq futures rose ahead of major earnings reports and the start of the Federal Reserve meeting. Salesforce gained 2.2% after landing a $5.6 billion U.S. Army contract. A partial government shutdown loomed with funding set to expire after midnight Friday.
AllianceBernstein stock jumps 7.5%; AB traders eye Fed week and Feb. 5 earnings

AllianceBernstein stock jumps 7.5%; AB traders eye Fed week and Feb. 5 earnings

AllianceBernstein units traded near $41.88 premarket Tuesday after jumping 7.49% Monday, with 1.63 million units changing hands. The firm’s assets under management rose to $867 billion in December, though net flows were slightly negative. No company statement has explained Monday’s surge. AllianceBernstein reports Q4 results before the market opens Feb. 5.
UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth shares fell 8.3% to $322.32 in premarket trading after CMS proposed a near-flat 0.09% average payment increase for 2027 Medicare Advantage plans and stricter rules on diagnosis data. The move triggered a broad selloff in managed-care stocks, with CVS Health and Humana also dropping sharply. UnitedHealth is set to report earnings and its 2026 outlook before the market opens. CMS will accept comments on the proposal until Feb. 25.
Keppel stock price nudges up in Singapore as traders brace for Feb 5 earnings

Keppel stock price nudges up in Singapore as traders brace for Feb 5 earnings

Keppel Ltd shares rose 0.37% to S$10.99 in afternoon trading Tuesday, recovering from a 0.6% drop Monday. Investors are watching for Keppel’s full-year results on Feb 5, with Keppel DC REIT reporting Jan 30. The company recently announced a 1.0GW Asia-Pacific data centre pipeline and a 25-year Bifrost Cable System lease deal. UOB Kay Hian maintained a “buy” rating with a S$11.70 target.
UOB stock price wobbles after JPMorgan downgrade as MAS review and earnings near

UOB stock price wobbles after JPMorgan downgrade as MAS review and earnings near

UOB shares slipped 0.3% to S$38.40 by mid-afternoon in Singapore, lagging DBS and OCBC as the Straits Times Index rose 1%. JPMorgan downgraded UOB to “underweight” last week, while Macquarie upgraded it to “outperform.” Analysts expect Q4 net profit to fall 16.7% year-on-year to S$1.28 billion, citing weaker fees and a tough comparison base. UOB will report full-year results on Feb. 24.
CapitaLand Investment stock price jumps to S$3.11 — traders eye MAS decision and Feb 11 results

CapitaLand Investment stock price jumps to S$3.11 — traders eye MAS decision and Feb 11 results

CapitaLand Investment shares rose nearly 2% to S$3.11 in Tuesday afternoon trading on the SGX, extending a 15% gain since January. The company will release its full-year 2025 results before market open on Feb. 11. Investors are watching Thursday’s Singapore monetary policy review, with most analysts expecting no change. Local property stocks outperformed as banking shares lagged.
Bloom Energy stock drops as Jefferies lifts target but stays bearish ahead of Feb. 5 results

Bloom Energy stock drops as Jefferies lifts target but stays bearish ahead of Feb. 5 results

Bloom Energy shares fell 3.7% to $139.62 Monday, underperforming the S&P 500’s 0.5% gain. Jefferies raised its price target to $92 but kept an Underperform rating, warning expectations are high. Investors await Bloom’s Feb. 5 results for updates on 2026 deployments and margins. Other fuel-cell stocks, including Plug Power and FuelCell Energy, also dropped.
1 46 47 48 49 50 202

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Go toTop